Tips for Treating Latent TB Infection in Children
This fact sheet includes information on treating latent TB infection in children, including the treatment regimens, administration tips, and monitoring recommendations.
This fact sheet includes information on treating latent TB infection in children, including the treatment regimens, administration tips, and monitoring recommendations.
The revised guidelines includes recommendations for specific administrative controls, environmental controls, and respiratory protection controls.
In this 60-minute webinar, a case presentation highlights challenges a nurse case manager navigated during the treatment of a patient with TB disease during the COVID-19 pandemic.
This pocket card provides information on the treatment of drug-susceptible TB disease. The pocket card is adapted from the 2016 Official American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America Clinical Practice Guidelines: Treatment of Drug-...
The guide is a quick reference tool on available methods for testing children for TB. Health care workers can refer to the guide for information on available TB testing methods, interpreting TB screening tests, as well as next steps.
This webinar focuses on risk communication around TB during the COVID-19 pandemic. The learning objectives for this webinar are:
• Recognize the emotional and psychological impact of the COVID-19 pandemic on health workers and TB patients
• Apply risk communication principles to...
This manual for clinicians provides guidelines for clinical care of persons with HIV/AIDS. This updated version incorporates many new insights, but the time-tested format has been retained – easy access to crucial facts for a busy clinician. The guide touches on every topic facing people with...
This report in the form of a notice to readers states that CDC in conjunction with the American Thoracic Society expects to issue new guidelines on screening and preventive therapy for TB that will include a recommendation on the use of the two-month regimen of daily rifampin and pyrazinamide (...